FDA 483 - North American Diagnostics - June 23, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of North American Diagnostics in Holly Hill, FL, revealed numerous significant quality system deficiencies related to their ORAL RAPID ™ SARS-CoV-2 Antigen Rapid Test Kit. The firm lacked established procedures for design control, production processes, process validation, acceptance activities, corrective and preventive actions, device distribution, complaint handling, and medical device reporting. Furthermore, the firm distributed its COVID-19 test kit without the required Emergency Use Authorization.
ID · 6e7764d8-50c0-4ee5-a1a4-3135cb3bd89f